Market revenue in 2023 | USD 20,847.5 million |
Market revenue in 2030 | USD 52,047.0 million |
Growth rate | 14% (CAGR from 2023 to 2030) |
Largest segment | Injectables |
Fastest growing segment | Injectables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Injectables, Skin Rejuvenation |
Key market players worldwide | Hologic Inc, AbbVie Inc, Galderma Group AG Registered Shares, Alma Lasers Ltd, UltraShape Ltd. (Syneron Medical), Johnson & Johnson, Merz Pharma, Lumenis, Bausch Health Companies Inc, Cutera Inc, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive aesthetic treatment market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 63.33% in 2023. Horizon Databook has segmented the U.S. non-invasive aesthetic treatment market based on injectables, skin rejuvenation covering the revenue growth of each sub-segment from 2018 to 2030.
Non-invasive aesthetic treatment market in the U.S. accounted for 85% of North America’s market. High disposable income and growing awareness about availability of a variety of aesthetic procedures are some of the factors responsible for market growth.
Rising prevalence of skin diseases, such as psoriasis, eczema, vitiligo, and acne, is also expected to boost the market. According to National Psoriasis Foundation 2019 statistics, around 7.5 million people were suffering from psoriasis in the U.S. According to an article published by American Society of Plastic Surgeons, the number of minimally invasive & surgical cosmetic procedures increased by nearly 1%, in 2020.
Around 295,331 non-invasive aesthetic procedures were performed in the country and botulinum toxin fillers, cellulite treatment, chemical peel, IPL treatment, & laser hair removal were the top five procedures performed.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. non-invasive aesthetic treatment market , including forecasts for subscribers. This country databook contains high-level insights into U.S. non-invasive aesthetic treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account